UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028618
Receipt number R000032752
Scientific Title Examination of the Effect of Self Monitoring on patients with Persistent Chemotherapy-Induced Peripheral Neuropathy
Date of disclosure of the study information 2017/08/10
Last modified on 2023/02/14 10:41:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of the Effect of Self Monitoring on patients with Persistent Chemotherapy-Induced Peripheral Neuropathy

Acronym

Effect of Self Monitoring with PCIPN

Scientific Title

Examination of the Effect of Self Monitoring on patients with Persistent Chemotherapy-Induced Peripheral Neuropathy

Scientific Title:Acronym

Effect of Self Monitoring with PCIPN

Region

Japan


Condition

Condition

Breast cancer, colon cancer, gynecological cancer

Classification by specialty

Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Examination of the effect of self monitoring on cancer patients with chronic peripheral neuropathy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

*The effect of self-management education

Key secondary outcomes

*The Comprehensive Assessment Scale for Chemotherapy-induced Peripheral Neuropathy in Survivors of Cancer(CAS-CIPN)
*Cancer-chemotherapy Concerns Rating Scale(CCRS)
*Improve self-care capacity
*Improvement of QOL (FACT-G)
*Improvement of self-efficacy (SEAC)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom Maneuver

Interventions/Control_1

Self Monitoring with PCIPN/ Regular care
Self-monitoring type (60 people, below intervention group) / knowledge provision type (60 people, control group) Self monitoring type with self-monitoring type further self-monitoring type (30 persons, the following record book group), smartphone application ), And intervention study is conducted according to the self-monitoring conceptual model created.In both the control group and the intervention group, an interview was conducted on the start date, and peripheral nerves Do you understand lifestyle movements that do not cause numbness and pain due to obstacles, methods of massage and cold / hot menstruation, differences between acute symptoms and chronic symptoms, necessity of properly communicating the symptoms of peripheral neuropathy to medical personnel Confirm and provide supplementary explanation about missing knowledge. Three weeks, six weeks, and nine weeks later, peripheral nerve disorders and living conditions were also confirmed through interviews in both the control group and the intervention group, and the presence or absence of intervention and the perception of peripheral neuropathy by the teaching materials being used Change, coping exercises to understand changes in behaviors
<Measurement date>
* 1st, 3rd, 4th: FACT-G, SEAC, Peripheral Neuropathy Scale, Anxiety Scale, Safety Daily Behavior Checklist, Thermometers and Troublesome Thermometers
* 2nd: FACT-G, SEAC, Peripheral Neurological Disorder Scale, Anxiety Scale, Psychological and Heterostatic Thermometers

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with colon cancer, breast cancer, gynecological cancer who received compliance with outpatient regimen including platinum drug and taxane drug more than three times. Including patients without peripheral neuropathy

Key exclusion criteria

For each physical or mental reason, each scale measurement, patient who is difficult to interview, patients who measured cognitive function with MINI - COG and was 3 points or less

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Kanda
Middle name
Last name Kiyoko

Organization

Gunma University Graduate School of Health Sciences

Division name

Department of Nursing

Zip code

371-8514

Address

3-39-22,Showa-machi Maebashi Gunma

TEL

027-220-8929

Email

kkanda@gunma-u.ac.jp


Public contact

Name of contact person

1st name Kiyoko
Middle name
Last name Kanda

Organization

Gunma University Graduate School of Health Sciences

Division name

Department of Nursing

Zip code

371-8514

Address

3-39-22,Showa-machi Maebashi Gunma

TEL

027-220-8929

Homepage URL


Email

kkanda@gunma-u.ac.jp


Sponsor or person

Institute

Gunma University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

MEXT JSPS KAKENHI Grant-in-Aid


Other related organizations

Co-sponsor

Niigata College of Nursing

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University

Address

Gunma Showa machi, Maebashi-city3-39-15

Tel

0272208929

Email

kkanda@gunma-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

群馬大学医学部附属病院(群馬県)
新潟県立中央病院(新潟県)


Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

65

Results

There was an interaction effect between the CG and SMG regarding self-efficacy scores. Scores were significantly higher in the SMG than in the CG after three weeks. Quality of life (QOL)scores were also higher in the SMG than in the CG. The self-monitoring intervention maintained the participants self-efficacy and QOL. This suggested its effectiveness on patients with peripheral neuropathy.

Results date posted

2022 Year 08 Month 16 Day

Results Delayed

Delay expected

Results Delay Reason

Because the analysis was delayed and the post was delayed

Date of the first journal publication of results


Baseline Characteristics


Participant flow

Study details were explained to a total of 81 cancer (breast and gynecological) and colorectal cancer patients who received outpatient treatment and met the requirements for the study; 77 consenting patients were selected for participation. The patients were randomly assigned to the CG (n=38) or the SMG (n=39) as a sequential enrollment method at each institution. However, certain participants did not complete the study period as they either declined to participate after the first and second time (control n=2, intervention n=3) or declined any treatment (intervention n=1). After excluding those with incomplete data, the final number of participants was 32 in the CG and 33 in the SMG. We did not supplement the dropouts or incompletely recorded (missing) data.

Adverse events

NONE

Outcome measures

CAS-CIPN,
GOG-Ntx,
DIT,
SEAC,
FACT-G

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 12 Day

Date of IRB

2017 Year 05 Month 02 Day

Anticipated trial start date

2017 Year 07 Month 30 Day

Last follow-up date

2020 Year 05 Month 29 Day

Date of closure to data entry

2020 Year 06 Month 05 Day

Date trial data considered complete

2020 Year 09 Month 30 Day

Date analysis concluded

2020 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2017 Year 08 Month 09 Day

Last modified on

2023 Year 02 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032752


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name